Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00759642
Title Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Kansas
Indications

estrogen-receptor positive breast cancer

progesterone-receptor positive breast cancer

Therapies

Lapatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.